GlassScriptPhysician profile
John G Pierce
NPI 1831289339
$1,498.69
in general payments reported to CMS, 2019-2025
24 companies · $63.54 in 2025
The $63.54 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $94.59 · 2021: $121 · 2022: $335 · 2023: $436 · 2024: $164 · 2025: $63.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $472.38 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $189.09 | 2019-2024 | |
| Alydia Health | $81.82 | 2021 | |
| Astellas Pharma US INC | $78.30 | 2019-2023 | Veozah |
| Myriad Women'S Health, INC. | $75.57 | 2023 | Myrisk |
| Organon LLC | $71.48 | 2022-2025 | Nexplanon, Jada System |
| Daiichi Sankyo INC. | $68.18 | 2020-2023 | Injectafer |
| Therapeuticsmd, INC. | $67.73 | 2019-2022 | |
| Pfizer INC. | $63.67 | 2019-2024 | |
| Amgen INC. | $62.90 | 2019-2020 | |
| Biogen, INC. | $32.72 | 2024 | Zurzuvae |
| Sumitomo Pharma America, INC. | $27.33 | 2023-2024 | Myfembree |
| Merck Sharp & Dohme LLC | $25.38 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $22.60 | 2020 | |
| Mayne Pharma Commercial LLC | $20.69 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $19.49 | 2020 | |
| Shield Therapeutics INC | $18.87 | 2023 | Accrufer |
| Coopersurgical, INC. | $16.83 | 2023 | Mara Console |
| Hologic Sales and Service, LLC | $16.32 | 2019 | |
| Avion Pharmaceuticals | $15.55 | 2022 | |
| Aspira Women'S Health INC | $13.84 | 2022 | |
| Axonics, INC. | $12.87 | 2022 | |
| Allergan, INC. | $12.55 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.